Overview
Dr. Mark Tullman is White Plains Hospital’s Associate Director of Multiple Sclerosis. After spending 14 years practicing medicine in his hometown of St. Louis, he was delighted to return to the greater New York metropolitan area and medical community in October 2025.
Dr. Tullman is highly rated in 3 conditions, according to our data. His top areas of expertise are Multiple Sclerosis (MS), Relapsing Multiple Sclerosis (RMS), Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease, and Neuromyelitis Optica.
His clinical research consists of co-authoring 6 peer reviewed articles. MediFind looks at clinical research from the past 15 years.
Graduate Institution
Residency
Specialties
Licenses
Board Certifications
Fellowships
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- PPO
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- EPO
- HMO
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER COMMERCIAL
- OTHER MEDICARE PART D
- INSURANCE PLAN
- MEDICARE MAPD
- MANAGED MEDICAID PLAN
- MEDICARE SNP
- EPO
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- HMO
- POS
- EPO
- HMO
- INDEMNITY
- POS
- PPO
- MEDICARE SNP
- OTHER MANAGED MEDICAID
- EPO
- HMO
- PPO
- OTHER MEDICAID
- STATE MEDICAID
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- EPO
- PPO
- EPO
- HMO
- PPO
- EPO
- HMO
- POS
- PPO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
170 Maple Avenue, Suite 309, White Plains, NY 10601
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Werner K Doyle M.D. PC
Orrin Devinsky is a Neurologist in New York, New York. Dr. Devinsky is highly rated in 31 conditions, according to our data. His top areas of expertise are Myoclonic Epilepsy, Dravet Syndrome, Seizures, Epilepsy, and Deep Brain Stimulation.
Dysautonomia Center LLP
Horacio Kaufmann is a Neurologist in New York, New York. Dr. Kaufmann is highly rated in 13 conditions, according to our data. His top areas of expertise are Familial Dysautonomia, Hajdu-Cheney Syndrome, Hereditary Sensory and Autonomic Neuropathy Type 2, and Orthostatic Hypotension.
CUIMC/Neurological Institute Of New York
Andrew B. Lassman, MD, FAAN, FASCO, is a Professor of Neurology and Associate Dean of Clinical Research Compliance at the Columbia University Vagelos College of Physicians and Surgeons. Dr. Lassman also serves as Chief of the Division of Neuro-Oncology and Vice Chair for Clinical Research in the Department of Neurology, and as Associate Director for Clinical Trials at the Herbert Irving Comprehensive Cancer Center. As a clinician-scientist, Dr. Lassman focuses both his research and clinical efforts on improving the understanding and treatment of brain tumors.Dr. Lassman has particular expertise in translational clinical trials for brain tumors, with molecular correlative analyses to understand the reasons for treatment success or failure, and to refine treatment paradigms. Dr. Lassman has led retrospective studies, single institution prospective clinical trials, and multicenter prospective trials conducted nationally through the National Cancer Institute sponsored National Clinical Trials Network. His contributions to the field of Neuro-Oncology have been recognized with numerous awards, including the Preuss Award in Neuro-Oncology from the American Academy of Neurology, the Boyer Clinical Research Award from Memorial Sloan-Kettering Cancer Center, and the Gary Lichtenstein Humanitarian Award from Voices Against Brain Cancer.Dr. Lassman earned his BS and MS degrees in Molecular Biophysics and Biochemistry, as part of a combined four-year program at Yale University. He attained his MD from Columbia University College of Physicians and Surgeons and completed Neurology residency at the Neurological Institute of New York, at NewYork-Presbyterian/Columbia University Irving Medical Center. Dr. Lassman completed his fellowship in Neuro-Oncology at Memorial Sloan-Kettering Cancer Center, where he joined the faculty and served as fellowship director, until his return to NewYork-Presbyterian/Columbia University Irving Medical Center. Dr. Lassman is highly rated in 15 conditions, according to our data. His top areas of expertise are Astrocytoma, Glioblastoma, Glioma, and Gliomatosis Cerebri.
Frequently Asked Questions about Dr. Mark Tullman
How do I make an appointment with Dr. Mark Tullman?
You can book an appointment with Dr. Mark Tullman by calling their office at 914-849-5300. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Mark Tullman a top-rated expert for Multiple Sclerosis (MS)?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Mark Tullman is classified as an Distinguished expert for Multiple Sclerosis (MS), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Mark Tullman specialize in?
While Dr. Mark Tullman is a Neurology, they have specific expertise in Multiple Sclerosis (MS), Relapsing Multiple Sclerosis (RMS), and Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Neurology.
Does Dr. Mark Tullman participate in research or clinical trials?
Yes. Dr. Mark Tullman has published 6 articles and abstracts on conditions like Multiple Sclerosis (MS). You can view a list of Dr. Mark Tullman's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Mark Tullman accept my insurance?
Dr. Mark Tullman accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 914-849-5300 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Multiple Sclerosis (MS)Dr. Tullman isDistinguished. Learn about Multiple Sclerosis (MS).
- Relapsing Multiple Sclerosis (RMS)Dr. Tullman isDistinguished. Learn about Relapsing Multiple Sclerosis (RMS).
- Advanced
- Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease
- Experienced
- Acute Flaccid Myelitis (AFM)Dr. Tullman isExperienced. Learn about Acute Flaccid Myelitis (AFM).
- EpilepsyDr. Tullman isExperienced. Learn about Epilepsy.
- Memory LossDr. Tullman isExperienced. Learn about Memory Loss.
- Neurogenic BladderDr. Tullman isExperienced. Learn about Neurogenic Bladder.
- Neuromyelitis OpticaDr. Tullman isExperienced. Learn about Neuromyelitis Optica.
- Optic NeuritisDr. Tullman isExperienced. Learn about Optic Neuritis.